The analysis found that across all the 339 appraisals carried out for the new medicines, the median gain in quality-adjusted ...
The FDA has approved Neurocrine Bioscience's Crenessity for classic congenital adrenal hyperplasia (CAH), the first drug for ...
Novo Nordisk has started building its first brand-new manufacturing facility in Denmark since the millennium, saying it plans ...
Dermatology specialist Galderma has claimed a second FDA approval for IL-31 inhibitor Nemluvio, adding atopic dermatitis to ...
Recruiting for clinical trials is hard… and expensive. And a large component of that time involves people sifting through ...
In a time when pharmaceutical companies no longer have the economic luxury of decades-long development cycles, indication ...
AbbVie has agreed a $200 million-plus takeover deal with Roche spinout Nimble Therapeutics that will give it control of a ...
Essentially, what Concr demonstrates is that training their algorithms on smaller, yet more diverse, data can lead to increased accuracy, due to the broader biological variability within that training ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback